Status:
UNKNOWN
Monocentric Study on the Use of Teriparatide in Children With hypoparathyroïdism
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Hypoparathyroidism
Eligibility:
All Genders
2-18 years
Brief Summary
Pediatric hypoparathyroidism is an orphan disease. Conventional management combines native and active vitamin D, calcium supplementation and sometimes phosphate binders, with the risk of long term hyp...
Eligibility Criteria
Inclusion
- Patients with hypoparathyroidism
- Patients treated with teriparatide
- Patients followed in the reference center for calcium and phosphate metabolism diseases of Lyon.
- For children under 18: patient and parent (s) / parent having been informed of the study and having expressed their non-opposition
Exclusion
- No social security support
Key Trial Info
Start Date :
June 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT04126941
Start Date
June 1 2019
End Date
December 1 2020
Last Update
October 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Néphrologie, Rhumatologie et Dermatologie Pédiatriques - Hôpital Femme Mère Enfant
Bron, France